Depletion of ILK drives the conversion of GBM stem cells from a heterogeneous population to a more homogenous one; thus, the FAK+MEK combination treatment may also target plasticity to provide broad activity across heterogeneous GBM stem cell models. Here, PTK2 is linked to glioblastoma.